Lemaitre Vascular Inc (LMAT)

Date: O: H: L: C: Vol:

Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.76%70.38	66.55	64.45	61.05	64.23
Cost Of Revenue	8.06%19.62	18.16	18.26	15.09	19.26
Gross Profit	4.89%50.76	48.40	46.19	45.96	44.97
	0.84%30.37	30.62	27.36	25.64	28.83
Research and Development	19.38%4.85	4.06	3.53	2.97	3.54
Interest Income/Expense	0.15%1.30	1.30	1.30	1.30	1.30
Operating Income/Loss	14.76%20.40	17.78	18.83	20.31	16.14
Income/Loss From Continuing Operations Before Tax	12.79%22.19	19.67	20.30	22.57	18.07
Income Tax Expense/Benefit	28.70%5.14	3.99	4.72	5.21	4.29
	8.74%17.05	15.68	15.58	17.36	13.78
Attributable To Parent	8.74%17.05	15.68	15.58	17.36	13.78
Basic Average Shares	0.25%22.86	22.80	0.02	22.66	22.61
Diluted Average Shares	6.51%24.53	23.03	0.01	24.39	22.89
Basic Earnings Per Share	8.70%0.75	0.69	0.69	0.77	0.61
Diluted Earnings Per Share	8.82%0.74	0.68	0.68	0.75	0.60
Common Stock Dividends	0.25	0.25	0.20	0.20	0.20